Effect of coenzyme Q10 Supplementation on Metabolic Syndrome Parameters, lipid peroxidation, hs-CRP and homocysteine in patients with metabolic syndrome.

Yazd University Of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新: 2018年2月22日

适应症

试验速览

暂无简介。

•1. Having the metabolic syndrome according to the NCEP ATP III definition:
•According to the NCEP ATP III definition of having at least 3 of the following conditions:
•a)Abdominal obesity (waist circumference =102 cm in men and= 88 cm in women)
•b) High blood pressure (systolic blood pressure=130 mm Hg and / or diastolic blood pressure=85 mm Hg)
•c)Low HDL-C (< 40 mg/ dl in men and < 50 mg/ dl in women)
•d)TG =150 mg/ dl
•e)FBS =100 mg/ dl
•2.Being the age limit from 35 to 55 years
•3.Patients with hypertension treated with anti-hypertensive drugs in the past 3 months have not changed and changes in drug therapy not occure during the study period.
•4.Patients with diabetes who their treatment in the past 6 weeks has not changed
•(Changes in drug therapy not occur during the study period )
•5. Consent to participate in the study.
•Exclusion criteria:
•1.Statin use in the last month
•2.History of cardiovascular disease in the past three months
•3.Having an active infection
•4.Risk of renal failure
•5.Liver disease (viral hepatitis, treatments for liver disease)
•6.Alcohol Consumption
•7.Pregnancy or taking contraceptive drugs
•8.History of hospitalization in the past 2 months
•9.consumption of Nutritional supplements such as vitamins, trace elements, antioxidants

发起方

Yazd University Of Medical Sciences